XML 49 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents financial information for each reportable segment (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2014
 
2013
 
2014
 
2013
Net Revenue:
 
 
 
 
 
 
 
Ambulatory Services
$
277,302

 
$
263,035

 
$
816,942

 
$
780,714

Physician Services
225,931

 
—

 
225,931

 
—

Total
$
503,233

 
$
263,035

 
$
1,042,873

 
$
780,714

 
 
 
 
 
 
 
 
Adjusted Segment EBITDA:
 
 
 
 
 
 
 
Ambulatory Services
$
47,871

 
$
45,566

 
$
145,738

 
$
138,523

Physician Services
48,016

 
—

 
48,016

 
—

Total
$
95,887

 
$
45,566

 
$
193,754

 
$
138,523

 
 
 
 
 
 
 
 
Adjusted Segment EBITDA:
$
95,887

 
$
45,566

 
$
193,754

 
$
138,523

Earnings from continuing operations attributable to noncontrolling interests
47,570

 
44,869

 
139,318

 
135,247

Interest expense, net
(39,055
)
 
(7,293
)
 
(52,909
)
 
(22,346
)
Depreciation and amortization
(20,866
)
 
(8,239
)
 
(37,620
)
 
(24,152
)
Share-based compensation
(2,424
)
 
(2,104
)
 
(7,388
)
 
(6,070
)
Transaction costs
(25,102
)
 
(110
)
 
(28,681
)
 
(285
)
Debt extinguishment costs
(16,887
)
 
—

 
(16,887
)
 
—

Gain on deconsolidation
—

 
—

 
3,411

 
2,237

Earnings from continuing operations before income taxes
$
39,123

 
$
72,689

 
$
192,998

 
$
223,154

 
 
 
 
 
 
 
 
Acquisition and Capital Expenditures:
 
 
 
 
 
 
 
Ambulatory Services (1)
$
5,759

 
$
49,348

 
$
45,207

 
$
80,166

Physician Services
2,339

 
—

 
2,339

 
—

Total
$
8,098

 
$
49,348

 
$
47,546

 
$
80,166

 
 
 
 
 
 
 
 
 
September 30, 2014
 
December 31, 2013
Assets:
 
 
 
Ambulatory Services
$
2,450,543

 
$
2,177,944

Physician Services
2,970,814

 
—

Total
$
5,421,357

 
$
2,177,944

                                    
(1)
Excludes the purchase price to acquire Sheridan.